UNITED
UNITED THERAPEUTICS Corp
Quick answer
UNITED is a pharma company (UTHR) headquartered in SILVER SPRING, MD, USA with 24 tracked pipeline programs.
Pipeline (24)
0.2 mg/kg ketamine
Depression
1 trials project1.0% C31G SAVVY vaginal gel
HIV Infections
2 trials project1:1:1 Blood Transfusion Ratio
Trauma
1 trials project2 mg Melatonin
Anxiety
1 trials project3-dimensional conformal radiation therapy
Head and Neck Cancer
1 trials project4-aminopyridine
Spinal Muscular Atrophy
1 trials project600 mg Ibuprofen
Tibial Fractures
1 trials projectALVAC-HIV vCP1521 + AIDSVAX
HIV Infection
1 trials projectAbemaciclib
Breast Cancer Female
1 trials projectActive CTC Assessment
Adenocarcinoma of the Prostate
1 trials projectAlbendazole
Helminthiasis
1 trials projectAlbendazole (400 mg) and/or Vitamin a
Malnutrition
1 trials projectAlemtuzumab
Kidney Transplantation
1 trials projectAlfuzosin
Kidney Stones
1 trials projectAmlodipine
Depression
1 trials projectAmoxycillin
Non-Severe Pneumonia With Wheeze
1 trials projectAnakinra 100mg and Placebo Depo-Medrone
Gout
1 trials projectAnastrozole
Breast Cancer
2 trials projectAnodal tDCS
Stroke
1 trials projectAntiplatelet (Aspirin, Dipyridamole, clopidogrel)
Cervical Artery Dissection
1 trials projectApixaban
Cerebral Vein Thrombosis
2 trials projectAromatase Inhibitors
Breast Cancer
1 trials projectAspirin
Node Positive HER2 Negative Breast Cancer
1 trials projectBCG (Tokyo 172) vaccine
Tuberculosis Infection
1 trialsDrugs (7)
Patents (8)
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related di
patentUS 12419941
Poultry drinking water-based vaccine delivery system and method
patentUS 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt t
patentUS 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus inf
patentUS 12410259
CD47 targeted therapies for the treatment of infectious disease
patentUS 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
patentUS 12397066
Delivery of gene therapy treatments
patentUS 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and a